Particle.news
Download on the App Store

Man Faints at Oval Office Event as Trump Unveils GLP‑1 Drug Price Deal

The White House said the attendee is okay, highlighting a briefing on GLP‑1 discounts negotiated with Lilly and Novo Nordisk.

Overview

  • The press event paused and resumed roughly 30 minutes later after on-site clinicians treated the man, with the White House saying he was okay.
  • Novo Nordisk said the man widely identified online as executive Gordon Findlay was not present, naming CEO Mike Doustdar and EVP Dave Moore as its attendees.
  • CMS Administrator Mehmet Oz and others assisted as the man's legs buckled behind President Trump, and reporters were escorted from the Oval Office during the response.
  • The announcement detailed agreements with Eli Lilly and Novo Nordisk to expand access to GLP‑1 medications through a planned TrumpRx platform, with officials touting steep discounts.
  • Eli Lilly CEO David Ricks said the attendee appeared to become light‑headed after standing in a warm room, though no official cause has been released as video of the incident spread widely online.